| Bioactivity | ML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively. ML 315 is used in cancer and neurological disease research[1]. |
| Name | ML 315 |
| CAS | 1440251-53-5 |
| Formula | C18H13Cl2N3O2 |
| Molar Mass | 374.22 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Coombs TC, et al. Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3654-61. |
ML 315
CAS: 1440251-53-5 F: C18H13Cl2N3O2 W: 374.22
ML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively. ML 315 is used in can
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.